Literature DB >> 3328732

High level expression of proinsulin in the yeast, Saccharomyces cerevisiae.

L S Cousens1, J R Shuster, C Gallegos, L L Ku, M M Stempien, M S Urdea, R Sanchez-Pescador, A Taylor, P Tekamp-Olson.   

Abstract

Human proinsulin (PI) has been expressed to a high level (100 mg/liter) as a human superoxide dismutase-PI fusion protein in the yeast, Saccharomyces cerevisiae. At the junction of the two proteins is a methionine residue, allowing PI to be released from the fusion by reaction with cyanogen bromide. The fusion is expressed using a regulated, hybrid promoter containing the regulatory region of the alcohol dehydrogenase II promoter and the 3' end of a glyceraldehyde-3-phosphate dehydrogenase promoter, allowing the recombinant yeast cells to be stably maintained. Production of the fusion protein is induced by growth in medium lacking a fermentable carbon source. The heterologous fusion protein is probably insoluble within the cell, since electron microscopy reveals the presence of 'inclusion bodies'. In a cell-free extract the fusion protein is also insoluble, but can be solubilized with sodium dodecyl sulfate, and cleaved with cyanogen bromide. The PI that is produced contains incorrect disulfide bonds. After sulfitolysis, the product can be easily purified, renatured, and processed to yield insulin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3328732     DOI: 10.1016/0378-1119(87)90190-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

1.  Homogenates of yeast cultures with engineered catalases F148V and V111A reveal higher specific activities after incubation at permissive temperature.

Authors:  M Zámocký; F Koller
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.099

Review 2.  The yeast expression system for recombinant glycosyltransferases.

Authors:  M Malissard; S Zeng; E G Berger
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

3.  Giant yeast cells with nonrecyclable ribonucleotide reductase.

Authors:  Emilie Ma; Arach Goldar; Jean-Marc Verbavatz; Marie-Claude Marsolier-Kergoat
Journal:  Mol Genet Genomics       Date:  2011-03-27       Impact factor: 3.291

4.  Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60.

Authors:  V Parissi; C Calmels; V R De Soultrait; A Caumont; M Fournier; S Chaignepain; S Litvak
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.

Authors:  R Solari; D Quint; H Obray; A McNamee; E Bolton; P Hissey; B Champion; E Zanders; A Chaplin; B Coomber
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

6.  Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: potential use for inhibitor screening.

Authors:  A B Caumont; G A Jamieson; S Pichuantes; A T Nguyen; S Litvak; C Dupont
Journal:  Curr Genet       Date:  1996-05       Impact factor: 3.886

7.  Stabilization of methionine-rich protein in Saccharomyces cerevisiae: targeting of BZN protein into the peroxisome.

Authors:  J M Nicaud; A Raynal; A Beyou; M Merkamm; H Ito; N Labat
Journal:  Curr Genet       Date:  1994 Nov-Dec       Impact factor: 3.886

8.  Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells.

Authors:  G A Keller; T G Warner; K S Steimer; R A Hallewell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.

Authors:  D Y Chien; Q L Choo; A Tabrizi; C Kuo; J McFarland; K Berger; C Lee; J R Shuster; T Nguyen; D L Moyer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Control of formation of active soluble or inactive insoluble baker's yeast alpha-glucosidase PI in Escherichia coli by induction and growth conditions.

Authors:  E Kopetzki; G Schumacher; P Buckel
Journal:  Mol Gen Genet       Date:  1989-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.